Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Cognition enhancer found devoid of neurotoxicity in vitro

Aug. 26, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Cephalon awarded patents for IGF-1

Aug. 26, 1997

FDA approves Watson's estazolam

Aug. 25, 1997

Amgen acquires rights to FKBP-neuroimmunophilin ligands

Aug. 25, 1997

New nonpeptide substance P antagonist from Pfizer

Aug. 25, 1997

New D4 antagonist may aid in the search for antipsychotic drugs

Aug. 25, 1997

Titan's Spheramine receives orphan drug designation

Aug. 25, 1997

FDA approves hand implant for quadriplegics

Aug. 22, 1997

Substance P antagonists discovered at Kotobuki

Aug. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...